The 41% who incorrectly selected “angiotensin-converting enzyme inhibitors” are unlikely to have been aware that some diuretics promote insulin resistance and angiotensin converting enzymes, in contrast, may be insulin sensitizing [15], the distinction between these two antihypertensive therapies in a patient with metabolic syndrome would be practice relevant. Here, INS is linked to metabolic syndrome.